Acarix AGM approves 2025 financials and elects board
No dividend was declared, and new board members Erik von Schenck and Marcin Gołębicki were elected.
See the latest news and media coverage for Acarix. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of acoustic cardiac diagnostic systems
acarix.comLast updated
In short: Acarix reported strong Q1 2026 growth with a 40% revenue increase and achieved EU MDR certification for its CADScor System.
No dividend was declared, and new board members Erik von Schenck and Marcin Gołębicki were elected.
Resolutions included adoption of financials, no dividend, re-election and new directors, and a CEO stock option program.
The committee recommends adding Erik von Schenck and Marcin Gołębicki, re-electing Jan Poulsen, Ken Nelson, and Tony Das, with unchanged board fees.
The meeting is held in Stockholm and contains proposals for employee stock option program to the CEO.
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report highlights...
2026-02-19. The following slide deck was published by Acarix AB (publ) in conjunction with their 2025 Q4 earnings call.
Acarix reported a strong financial performance in Q4 2025, with a 26% increase in global revenue to SEK 2.1 million, driven by significant growth in...
OKLAHOMA CITY, Feb. 4, 2026 /PRNewswire/ -- Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR...
Track Acarix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.